Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Azelis Group NV's accounts receivables for the quarter that ended in Jun. 2026 was €700 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Azelis Group NV's Days Sales Outstanding for the quarter that ended in Jun. 2026 was 58.64.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Azelis Group NV's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was €-7.28.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Azelis Group NV's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Azelis Group NV's accounts receivable are only considered to be worth 75% of book value:
Azelis Group NV's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Azelis Group NV Accounts Receivable Related Terms
Azelis Group NV Accounts Receivable Historical Data
* Premium members only.
The historical data trend for Azelis Group NV's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azelis Group NV (FRA:2R7) has a Accounts Receivable of €700 Mil as of Jun. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Azelis Group NV and its competitors.
Is Azelis Group NV's Accounts Receivable too high?
Azelis Group NV's current Accounts Receivable is €700 Mil. Overall, Azelis Group NV has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azelis Group NV's Accounts Receivable compare to LIN and SHW?
Azelis Group NV's Accounts Receivable of €700 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Chemicals company?
A good Accounts Receivable depends on the Chemicals industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Azelis Group NV and its competitors. Azelis Group NV's current Accounts Receivable is €700 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azelis Group NV stock overvalued right now?
Based on GuruFocus' analysis, Azelis Group NV (FRA:2R7) is currently considered Modestly Undervalued. The stock's GF Value™ is €17.24, compared to a current price of €12.18 — trading 29.4% below its estimated fair value. The current Accounts Receivable is €700 Mil. Azelis Group NV's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Azelis Group NV (FRA:2R7), the current Accounts Receivable is €700 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Azelis Group NV (FRA:2R7) Overvalued in 2026?
Based on GuruFocus' analysis, Azelis Group NV stock appears to be undervalued.
The current stock price of €12.18 is trading 29.4% below its estimated GF Value™ of €17.24.
GuruFocus considers Azelis Group NV to be Modestly Undervalued.
Key valuation signals for FRA:2R7:
Accounts Receivable: €700 Mil
GF Value™: €17.24 vs. price of €12.18 (29.4% below fair value)
No single metric tells the full story. See the FRA:2R7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Azelis Group NV is an innovation service provider and distributor of speciality chemicals and food ingredients. The Group provides innovation services, multi-product formulations, technical and regulatory expertise, co-creation support, digital solutions, and supply chain services. It serves Food & Nutrition, Animal Nutrition, Personal Care, Home Care & Industrial Cleaning, Pharmaceuticals & Healthcare, Agriculture & Environmental Solutions, Flavours & Fragrances, and Nutraceuticals. The Group operates through four segments: EMEA, Americas, Asia Pacific, and Group holding & other, covering operating companies across Europe, the Middle East and Africa, the United States, Canada, Mexico and South America, Asia, and the Pacific region.
81GF Score
Get the complete analysis for FRA:2R7
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2R7 has been successfully added to your 
